Emla and Prochlorperazine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Emla (lidocaine; prilocaine) and Prochlorperazine (prochlorperazine). Common drug interactions include haematocrit decreased among females and anaemia among males.
The phase IV clinical study analyzes what interactions people have when they take Emla and Prochlorperazine. It is created by eHealthMe based on reports of 115 people who take the same drugs from the FDA, and is updated regularly.
What is Emla?
Emla has active ingredients of lidocaine; prilocaine. eHealthMe is studying from 5,276 Emla users. Check the latest studies of Emla.
What is Prochlorperazine?
Prochlorperazine has active ingredients of prochlorperazine. It is often used in nausea. eHealthMe is studying from 14,632 Prochlorperazine users. Check the latest studies of Prochlorperazine.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
115 people who take Emla and Prochlorperazine together, and have interactions are studied.

What are the common drug interactions of Emla and Prochlorperazine, by gender? *
What are the common drug interactions of Emla and Prochlorperazine, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Emla and Prochlorperazine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Emla (5,276 reports)
- Prochlorperazine (14,632 reports)
Browse all drug interactions of Emla and Prochlorperazine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Emla:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Prochlorperazine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Emla and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Prochlorperazine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on lidocaine; prilocaine and prochlorperazine (the active ingredients of Emla and Prochlorperazine, respectively), and Emla and Prochlorperazine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Tamsulosin Hydrochloride and Gabapentin - a second ago
- Urination - Excessive At Night and Dizziness - 6 seconds ago
- Could Xalkori cause Nausea? - 6 seconds ago
- Urinary Incontinence and Back Pain - 8 seconds ago
- Could Coreg cause Lip Swelling? - 9 seconds ago
- Could Humira cause Vitreous Haemorrhage? - 11 seconds ago
- Urinary Retention and Lymphoedema - 12 seconds ago
- Upper Respiratory Tract Congestion and Drowsiness - 15 seconds ago
- Drug interactions of Avapro and Nitrolingual - 18 seconds ago
- Could Alendronate Sodium cause Hyperkeratosis? - 25 seconds ago